Deprescribing is a holistic process to identify medications that can be ceased, substituted or reduced. This process can improve the health of older patients and also enhance their compliance to the prescribed medications which are actually beneficial. Recommendations and guidelines have been elaborated for extensively prescribed drugs. In clinical cardiology the process of deprescribing is a challenge for doctors because of withdrawal-related adverse effects, but it may be applied in certain clinical conditions such as the discontinuation of statin prescription in patients with advanced senile dementia and those with limited life expectancy. Deprescribing is also focussed on the scarcely known effects of prolonged therapy after the acute phase of a disease is over, especially when continuation may signify potential life-long treatment. There needs to be collaboration between the consultant cardiologist who first prescribes medications and family doctors who are responsible for the long-term care of the patient and reviewing prescribed medications may be necessary.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00015385.2019.1593286 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Getting fit for hip and knee replacement: The Fit-Joints multimodal intervention for frail patients with osteoarthritis - a pilot randomized controlled trial.
J Frailty Aging
March 2025
Department of Health Research Methodology, Evidence and Impact, McMaster University, Hamilton, ON, Canada; The Research Institute of St Joseph's Healthcare, Hamilton, ON, Canada; Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa. Electronic address:
Background: Older adults with frailty have high risk for poor postoperative outcomes.
Objective: To evaluate the feasibility of a multimodal prehabilitation program in older adults with frailty awaiting hip or knee replacement.
Design: Parallel two-arm randomized controlled pilot trial.
Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians.
JAMA Netw Open
March 2025
Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Importance: The use of benzodiazepine receptor agonists (BZRA) poses serious health risks to older adults. Although several guidelines recommend deprescribing, implementation in clinical practice remains limited.
Objective: To identify physicians' barriers to and enablers of deprescribing BZRA in adults aged 65 years and older taking a BZRA for sleep problems; to determine factors associated with hospital physicians' intention to deprescribe BZRA and their self-reported routine BZRA deprescribing.
Exploring the need for a clinical decision support system for deprescribing - A qualitative interview study.
Explor Res Clin Soc Pharm
March 2025
Department of Clinical Pharmacology, County Council of Östergötland/Region Östergötland, Linköping, Sweden.
Background: Deprescribing (i.e., the process of discontinuing an inappropriate medication) requires time, knowledge, and care, but there is a lack of education, support, and guidelines for this important clinical task.
View Article and Find Full Text PDFFactors Influencing General Practitioners' Deprescribing Decisions for Older Adults, with Insights into Frailty: a Qualitative Study in Greek Primary Care.
Drugs Aging
February 2025
Department of Social Medicine, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Introduction: Polypharmacy is increasing among older individuals worldwide. Deprescribing has been suggested as a strategy to reduce polypharmacy, but it has had a limited impact.
Objective: This study investigated the facilitators and barriers to deprescribing in older adults, as perceived by primary care general practitioners, focusing particularly on factors influencing deprescribing in frail individuals.
Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies.
Lancet Diabetes Endocrinol
February 2025
Department of Medicine, Upstate Medical University, Syracuse, NY, USA.
Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ability to perform self-care. Most diabetes guidelines focus on improving glycaemia through addition of medications, but few address strategies to reduce medication burden for older adults-a concept known as deprescribing. Strategies for deprescribing might include stopping high-risk medications, decreasing the dose, or substituting for less harmful agents.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!